Order results by:
Issue | Title | |
Vol 12, No 4 (2019) | Comparative clinical and economic analysis of using SYSADOA drugs containing chondroitin sulphate or influencing its biosynthesis in the treatment of patients with stage II knee osteoarthritis | Abstract similar documents |
I. V. Sarvilina, A. N. Galustyan, A. K. Hadzhidis, I. S. Sardaryan, N. V. Lavrov, O. A. Gromova, Yu. S. Prokofieva | ||
"... containing chondroitin sulfate or modifying its biosynthesis in patients with stage II knee osteoarthritis ..." | ||
Vol 13, No 4 (2020) | Meta-analysis of clinical trials of osteoarthritis treatment effectiveness with Chondroguard | Abstract similar documents |
I. Yu. Torshin, A. M. Lila, A. V. Naumov, A. Yu. Kochish, L. I. Alekseeva, E. A. Taskina, I. V. Sarvilina, A. N. Galustyan, A. N. Gromov, A. K. Khadzhidis, L. V. Vasilieva, E. F. Yevstratova, M. I. Udovika, O. A. Gromova | ||
Vol 15, No 3 (2022) | Prospects for the use of chondroitin sulfate and glucosamine sulfate in the treatment of patients with obesity-associated osteoarthritis (metabolic syndrome) | Abstract similar documents |
I. Yu. Torshin, О. A. Gromova, A. M. Lila | ||
"... chondroitin sulfates (CS) lead to chronic inflammation and the development of a complex of comorbid ..." | ||
Vol 14, No 1 (2021) | Differences in the standardization of medicinal products based on extracts of chondroitin sulfate | Abstract similar documents |
O. A. Gromova, I. Yu. Torshin, B. Ts. Zaychik, E. V. Shikh, A. O. Ruzhitskiy, A. N. Galustyan, I. S. Sardaryan, I. V. Sarvilina | ||
"... chondroitin sulfate (CS) based on natural extracts. Material and methods. Five samples were studied for each ..." | ||
Vol 13, No 2 (2020) | Is it worthwhile rethinking the positive experience of the last 50 years of using chondroitin sulfates against atherosclerosis? | Abstract similar documents |
A. M. Lila, I. Yu. Torshin, O. A. Gromova | ||
"... Chondroitin sulfate (CS) and glucosamine sulfate (GS) are used in the treatment of osteoarthritis ..." | ||
Online First | Osteoarthritis therapy misconcepts | Abstract similar documents |
O. A. Shavlovskaya, О. А. Gromova, I. Yu. Torshin, I. D. Romanov | ||
"... are prescribed (according to the opinion of European experts (2019)) that are as follows: chondroitin sulfate (CS ..." | ||
Vol 13, No 4 (2020) | Acute issues in the pharmacotherapy of hand osteoarthritis | Abstract similar documents |
O. A. Gromova, I. Yu. Torshin, A. V. Naumov, L. V. Vasilyeva, Ye. F. Yevstratova, А. N. Gromov | ||
"... therapy include steroid drugs, chondroitin sulfate (CS), glucosamine sulfate (GS), and vitamin D ..." | ||
Vol 15, No 1 (2022) | Perioperative pharmacotherapy for endoprosthetics: potential of chondroitin sulfate and glucosamine sulfate | Abstract similar documents |
I. Yu. Torshin, T. B. Minasov, N. V. Zagorodniy, A. M. Lila, O. A. Gromova | ||
"... . The unique spectrum of anti-inflammatory effect of chondroprotectors based on chondroitin sulfate ..." | ||
Vol 14, No 3 (2021) | The concept of syndromic diagnoses of osteoarthritis and back pain as a cause of therapy failure | Abstract similar documents |
M. V. Putilina, N. V. Teplova, O. S. Gerasimova | ||
"... -acting drugs containing chondroitin sulfate (Chondroguard®), which will accelerate the onset ..." | ||
Vol 14, No 4 (2021) | Hepatoprotective effects of chondroitin sulfate and glucosamine sulfate | Abstract similar documents |
I. Yu. Torshin, A. M. Lila, O. A. Gromova | ||
"... Background. Long-term use of chondroprotective agents – chondroitin sulfate (CS) and glucosamine ..." | ||
Vol 14, No 4 (2021) | Prospects of using chondroprotectors for the treatment of pulmonary pathology | Abstract similar documents |
I. Yu. Torshin, O. A. Gromova, A. G. Chuchalin | ||
"... Background. The complex mechanisms of action of chondroitin sulfate (CS) and glucosamine sulfate ..." | ||
Vol 16, No 2 (2023) | From misconceptions to reasonable osteoarthritis patients therapy | Abstract similar documents |
O. A. Shavlovskaya, О. А. Gromova, I. Yu. Torshin, I. D. Romanov | ||
"... of European experts (2019): chondroitin sulfate (CS), glucosamine sulfate (GS), diacerein, avocado soybean ..." | ||
Online First | Disease-modifying osteoarthritis drugs (DMOADs): new trends in osteoarthritis therapy | Abstract similar documents |
O. A. Shavlovskaya, V. V. Omelyanovskiy, O. A. Gromova, A. Yu. Kochish, Yu. D. Yukhnovskaya, I. D. Romanov, I. A. Bokova | ||
"... substances can be considered as potential DMOADs: chondroitin sulfate, glucosamine sulfate, undenatured type ..." | ||
1 - 13 of 13 Items |
Search tips:
- Search terms are case-insensitive
- Common words are ignored
- By default articles containing any term in the query are returned (i.e., OR is implied)
- Make sure that a word exists in an article by prefixing it with +; e.g., +journal +access scholarly academic
- Combine multiple words with AND to find articles containing all terms; e.g., education AND research
- Exclude a word by prefixing it with - or NOT; e.g., online -politics or online NOT politics
- Search for an exact phrase by putting it in quotes; e.g., "open access publishing". Hint: Quoting Chinese or Japanese words will help you to find exact word matches in mixed-language fields, e.g. "中国".
- Use parentheses to create more complex queries; e.g., archive ((journal AND conference) NOT theses)